Karyotypic analysis of 32 malignant epithelial ovarian tumors

Cancer Genetics and Cytogenetics

Volumn 96, Issue 2, 1997, Pages 166-173

  Deger, Randolph B ^a   Faruqi, Shamim A ^a   Noumoff, Joel S ^a  

^a CROZER CHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CHROMOSOME 1P; CHROMOSOME 6P; CHROMOSOME ANALYSIS; CHROMOSOME MARKER; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 1; CLINICAL ARTICLE; CONTROLLED STUDY; DIPLOIDY; FEMALE; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE 46,XX; KARYOTYPING; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; OVARY CANCER; PRIORITY JOURNAL;

CARCINOMA; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 6; CYSTADENOCARCINOMA; EPITHELIUM; FEMALE; HUMANS; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 0030789220     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00327-5     Document Type: Article

References (56)

1. Sandberg AA (1990): The Chromosomes in Human Cancer and Leukemia, 2nd ed., Elsevier Science Publishing Co., New York.
2. Mitelman F (1991): Catalog of Chromosome Aberrations in Cancer, Ed. 4, Wiley-Liss, New York.
3. Dalla-Favera R, Bregni M, Erikson J, Gallo RC, Croce CM (1982): Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 79:7824-7827.
4. Nowell PC (1976): The clonal evolution of tumor cell populations. Science 194:23-28.
5. Foulds L (1969): Neoplastic Development, vol. I., Academic Press, New York.
6. Mackillop WJ, Trent JM, Steward SS, Buick RN (1983): Tumor progression studied by analysis of cellular features of serial ascitic ovarian carcinoma tumors. Cancer Res 43: 874-878.
7. Kusyk CJ, Seski JC, Medlin WV, Edwards CL (1981): Progressive chromosome changes associated with different sites of one ovarian carcinoma. J Natl Cancer Inst 66:1021-1025.
8. ISCN (1995): Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. F. Mitelman, ed. S. Karger, Basel.
9. Pejovic T, Heim S, Mandahl N, Baldetorp B, Elmfors B, Floderus UM, Furgyik S, Helm G, Himmelmann A, Willen H, Mitelman F (1992): Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosom Cancer 4:58-68.
10. Trent JM, Salmon SE (1979): Karyotypic analysis of human ovarian carcinoma cells cloned in agar. Am J Hum Genet 31:112A.
11. Trent JM, Salmon SE (1981): Karyotypic analysis of human ovarian carcinoma cells cloned in short term agar culture. Cancer Genet Cytogenet 3:279-291.
12. Lechner JF, LaVeck MA (1985): A serum-free method for culturing normal human bronchial epithelial cells at clonal density. J Tissue Cult Methods 9:43-48.
13. Crickard K, Crickard U, Yoonessi M (1983): Human ovarian carcinoma cells maintained on extracellular matrix versus plastic. Cancer Res 43:2762-2767.
14. Crickard K, Crickard U, Yoonessi M, Caglar H (1986): ECM-coated culture dishes: An in vitro model for primary human gynecologic tumors. Cancer Genet Cytogenet 19:51-56.
15. Roberts CG, Tatterstall MHN (1987): High quality metaphases from solid ovarian tumors. Cancer Genet Cytogenet 27:9-13.
16. Roberts CG, Tatterstall MHN (1990): Cytogenetic study of solid ovarian tumors. Cancer Genet Cytogenet 48:243-253.
17. Whang-Peng J, Knutsen T, Douglass EC, Chu E, Ozols RF, Hogan WM, Young RC (1984): Cytogenetic studies in ovarian cancer. Cancer Genet Cytogenet 11:91-106.
18. Gallion HH, Powell DE, Smith LW, Morrow JK, Martin AW, Van Nagell JR, Donaldson ES (1990): Chromosome abnormalities in human epithelial ovarian malignancies. Gynecol Oncol 38:473-477.
19. Jenkyn DJ, McCarenty AJ (1987): A chromosome study of three ovarian tumors. Cancer Genet Cytogenet 26:327-337.
20. Augustus M, Bruderlein S, Gebhart E (1986): Cytogenetic and cell cycle studies in metastatic cells from ovarian carcinomas. Anticancer Res 6:283-290.
21. Olinici CD, Galatir N, Lazarov P, Giurgiuman M (1973): Chromosomes in malignant gynecological effusions. Neoplasma 20:311-324.
22. - marker chromosome. Cytobios 42:15-24.
23. Atkin NB, Baker MC (1987): Abnormal chromosomes including small metacentrics in 14 ovarian cancers. Cancer Genet Cytogenet 26:355-361.
24. Bello MJ, Key JA (1990): Chromosome aberrations in metastatic ovarian cancer: Relationship with abnormalities in primary tumors Int J Cancer 45:50-54.
25. Bullerdiek J, Bartnitzke S, Kahrs E, Schloot W (1985): Further evidence for nonrandom chromosome changes in carcinoma cells - A report of 28 cases. Cancer Genet Cytogenet 16:33-43.
26. Samuelson J, Kat S, Schwartz PE, Yang-Feng TI (1988): Chromosome evolution through tumor progression in ovarian cancer. Am J Hum Genet 43 (suppl):A33.
27. Hill SM, Rodgers CS, Hulten MA, Wilson AP (1984): Cytogenetics of a cell line derived from an ovarian papillary serous cystadenocarcinoma. Cancer Genet Cytogenet 12:321-327.
28. Buick Rn, Pullano R, Trent JM (1985): Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res 45:3668-3676.
29. Wolf CR, Hayward IP, Lawrie SS, Buckton K, McIntyre MA, Adams DJ, Lewis AD, Scott ARR, Smyth JF (1987): Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int J Cancer 38:695-702.
30. Woods LK, Morgan RT, Quinn LA, Moor GE, Semple TU, Stedman KE (1979): Comparison of four new cell lines from patients with adenocarcinoma of the ovary. Cancer Res 39:4449-4459.
31. Sheer D, Sheppard DM, Gorman PA. Ward B, Whelan RDH, Hill BT (1987): Cytogenetic analysis of four ovarian carcinoma cell lines. Cancer Genet Cytogenet 26:339-349.
32. Kusyk CJ, Turpening EL, Edwards CL, Wharton JT, Copeland LJ (1982): Karyotype analysis of four solid gynecologic tumors. Gynecol Oncol 14:324-338.
33. Lambert B, Ringborg U, Harper E, Lindblad A (1978): Sister chromatid exchanges in lymphocyte cultures of patients receiving chemotherapy for malignant disorders. Cancer Treat Rep 62:1413-1419.
34. Mamaeva SE, Mamaev NN, Jartseva NM, Belyaeva LV, Scherbakova EG (1983): Complete or partial trisomy of the long arm of chromosome 1 in patients with various hematologic malignancies. Human Genet 63:107-112.
35. Palmer RG (1985): Drug induced chromosome damage. Saudi Med J 6:424-434.
36. Palmer RG, Dore CJ, Denman Am (1984): Chlorambucil induced chromosome damage to human lymphocytes is dose dependent and cumulative. Lancet 1:246-249.
37. Aten JA, Kooi MW, Stap J, Kipp JB, Barendsen GW (1987): X-ray and neutron induced chromosome damage detected by flow cytometry compared to cell lethality and chromosome structural changes. Radiat Res 110:329-339.
38. Barrios L, Caballin MR, Miro R, Fuster C, Guedea F, Subias A, Egozcue J (1990): Cytogenetic effects of radiotherapy: Frequency and types of chromosome aberrations. Int J Radiation Oncol Biol Phys 19:371-375.
39. Kiechle-Schwarz M, Bauknecht T, Karck U, Kommos F, Du Bois A, Pfleiderer A (1994): Recurrent Cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas. Gynecol Oncol 55:198-205.
40. Pejovic T, Heim S, Mandahl N, Elmfors B, Floerus UM, Fur-gyik S, Helm G, Willen H, Mitelman F (1989): Consistent occurrence of 19p+ marker chromosome and loss of lip material in ovarian seropapillary cystadenocarcinomas. Genes Chromosom Cancer 1:167-171.
41. Panani A, Ferti-Passantonopoulou A (1985): Common marker chromosomes in ovarian cancer. Cancer Genet Cytogenet 16:65-71.
42. Wake N, Hreshchyshyn MM, Piver SM, Matsui S, Sandberg AA (1980): Specific cytogenetic changes in ovarian cancer involving chromosomes 6 and 14. Cancer Res 40:4512-4518.
43. Tanaka K, Boice CR, Testa JR (1989): Chromosome aberrations in nine patients with ovarian cancer. Cancer Genet Cytogenet 43:1-14.
44. Pejovic T, Heim S, Mandahl N, Elmfors B, Floderus UM, Furgyik S, Helm G. Willen H. Mitelman F (1990): Trisomy 12 is a consistent chromosomal aberration in benign ovarian tumors. Genes Chromosom Cancer 2:48-52.
45. Lee JS, Pathak S, Hopwood V, Tomasovic B, Mullins TD, Baker FL, Spitzer G, Neidhart JA (1987): Involvement of chromosome 7 in primary lung tumors and nonmalignant normal lung tissue. Cancer Res 47:6349-6352.
46. Yang-Feng TL, Li S, Leung W-Y, Carcangiu ML, Schwartz PE (1991): Trisomy 12 and K-ras-2 amplification in human ovarian tumors. Int J Cancer 48:678-681.
47. Samuelson J, Leung WY, Schwartz PE, Ng H-T, Yang-Feng T (1990): Trisomy 12 in various ovarian tumors of benign to low malignancy. Am J Hum Genet 47 (suppl):A16.
48. Pejovic T, Heim S, Orndal C, Jin Y, Mandahl N, Willen H, Mitelman F (1990): Simple numerical chromosome aberrations in well-differentiated malignant epithelial tumors. Cancer Genet Cytogenet 48:95-101.
49. Persons DL, Hartmann LC, Herath JF, Borell TJ, Cliby WA, Keeney GL, Jenkins RB (1993): Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas. Am J Pathol 142:733-741.
50. Reichmann A, Martin P, Levin B (1982): Karyotypic findings in a colonic villous adenoma. Cancer Genet Cytogenet 7:51-57.
51. Bardi G, Pandis N, Fenger C, Heim S (1995): Trisomy 7 as the sole cytogenetic aberration in the epithelial component of a colonic adenoma. Cancer Genet Cytogenet 82:82-84.
52. Teyssier JR, Adnet JI, Pigeon F, Bajolle F (1985): Chromosomal changes in an ovarian granulosa cell tumor: Similarity with carcinoma. Cancer Genet Cytogenet 14:147-152.
53. Crickard K, Marinello MJ, Crickard U, Satchidanand SK, Yoonessi M, Caglar H (1986): Borderline malignant serous tumors of the ovary maintained on extracellular matrix: Evidence for clonal evolution and invasive potential. Cancer Genet Cytogenet 23:135-143.
54. Burks RT, Sherman ME, Kurman RJ (1995): Micropapillary serous carcinoma of ovary-peritoneum: A distinctive type of low-grade serous carcinoma. Mod Pathol 8:A495.
55. Trent JM, Thompson FH, Buick RN (1985): Generation of clonal variants in a human ovarian carcinoma studied by chromosome banding analysis. Cancer Genet Cytogenet 44: 153-161.
56. Noumoff JS, LiVolsi VA, Satyaswaroop PG, Deger RB, Faruqi SA (1995): Characterization of a lethal human endometrial carcinoma cell line (NOU-1) with 46,XX genome. Proceedings of the 6th International Workshop on Chromosomes in Solid Tumors, Philadelphia, PA.